Q3 2025 Hims & Hers Health Inc Earnings Call Transcript
Key Points
- Hims & Hers Health Inc (HIMS) reported a 49% year-over-year revenue growth, reaching nearly $600 million in the third quarter.
- The company saw a 50% increase in subscribers using personalized solutions, contributing to significant revenue growth.
- Hims & Hers Health Inc (HIMS) is expanding its international presence, with plans to launch in Canada and further investments in Europe.
- The company is actively pursuing strategic partnerships, such as discussions with Novo Nordisk and a partnership with Marius Pharmaceuticals.
- Hims & Hers Health Inc (HIMS) is investing in new specialties like menopause and low testosterone, which are expected to drive long-term growth.
- Gross margins declined over 2 points quarter over quarter to 74%, impacted by lower intra-quarter revenue recognized per shipment.
- General and administrative costs increased due to the integration of ZAVA and hiring of new leadership talent.
- The company is experiencing headwinds from the transition away from generic on-demand sexual health solutions.
- There are near-term margin headwinds expected from price reductions in compounded GLP-1 treatment plans.
- Hims & Hers Health Inc (HIMS) anticipates a temporary pause in year-over-year margin expansion due to ongoing investments.
Thank you for standing by. My name is Eric, and I will be your conference operator today. At this time, I would like to welcome everyone to the Hims & Hers third-quarter 2025 earnings call. (Operator Instructions)
I would now like to turn the call over to Bill Newby, Head of Investor Relations. Please go ahead.
Good afternoon, everyone, and welcome to the Hims & Hers Health third-quarter 2025 earnings call.
Today, after the market closed, we released this quarter's shareholder letter, a copy of which you can find on our website at investors.hims.com.
On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer; and Yemi Okupe, our Chief Financial Officer.
Before I hand it over to Andrew, I do remind you of legal safe harbor and cautionary declarations. Certain statements and projections of future results made in this presentation constitute forward-looking statements that are based on among other things, our current market,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
